Mehrnaz Hamedani
Overview
Explore the profile of Mehrnaz Hamedani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caneva S, Hamedani M, Pesaresi A, Mori L, Marzi A, Pellegrino L, et al.
Eur J Neurol
. 2025 Mar;
32(3):e16567.
PMID: 40087849
Background: Idiopathic normal pressure hydrocephalus (iNPH) is a multifactorial progressive disease affecting cognition, gait, and urinary continence, potentially reversible, or at least improvable, by a prompt surgical intervention. Given its...
2.
Hamedani M, Caneva S, Mancardi G, Ali P, Fiaschi P, Massa F, et al.
J Alzheimers Dis
. 2024 Sep;
101(4):1083-1106.
PMID: 39269840
Background: Alzheimer's disease (AD) is the most common neurodegenerative disorder which primarily involves memory and cognitive functions. It is increasingly recognized that motor involvement is also a common and significant...
3.
Picasso R, Zaottini F, Pistoia F, Beronio A, Bovis F, Hamedani M, et al.
Muscle Nerve
. 2023 Jun;
68(2):184-190.
PMID: 37303243
Introduction/aims: The reason for the variable rate of progression of patients with carpal tunnel syndrome (CTS) to thenar muscles impairment is not fully understood. The aim of this study was...
4.
Gandoglia I, Schirinzi E, Hamedani M, Reale N, Siri G, Cecconi R, et al.
Neurol Sci
. 2022 Oct;
44(1):229-236.
PMID: 36190685
Timely access to medical assistance is the first crucial step to improving clinical outcomes of stroke patients. Many educational campaigns have been organized with the purpose of making people aware...
5.
Hamedani M, Prada V, Tognetti P, Leoni V, Schenone A
Neurol Sci
. 2022 Apr;
43(11):6619.
PMID: 35445957
No abstract available.
6.
Hamedani M, Prada V, Tognetti P, Leoni V, Schenone A
Neurol Sci
. 2022 Apr;
43(6):3999-4001.
PMID: 35366114
No abstract available.
7.
Gemelli C, Geroldi A, Massucco S, Trevisan L, Callegari I, Marinelli L, et al.
Life (Basel)
. 2022 Mar;
12(3).
PMID: 35330153
Charcot-Marie-Tooth (CMT) disease is the most commonly inherited neurological disorder. This study includes patients affected by CMT during regular follow-ups at the CMT clinic in Genova, a neuromuscular university center...
8.
Tamburin S, Park S, Schenone A, Mantovani E, Hamedani M, Alberti P, et al.
Crit Rev Oncol Hematol
. 2021 Dec;
171:103575.
PMID: 34968623
Pharmacological strategies for chemotherapy-induced peripheral neurotoxicity (CIPN) are very limited. We systematically reviewed data on rehabilitation, exercise, physical therapy, and other physical non-pharmacological interventions and offered evidence-based recommendations for the...
9.
Park S, Tamburin S, Schenone A, Kleckner I, Velasco R, Alberti P, et al.
Expert Rev Neurother
. 2021 Dec;
22(1):65-76.
PMID: 34894974
Introduction: Chemotherapy-induced peripheral neurotoxicity (CIPN) remains a significant toxicity in cancer survivors without preventative strategies or rehabilitation. Exercise and physical activity-based interventions have demonstrated promise in reducing existing CIPN symptoms...
10.
Raglio A, Panigazzi M, Colombo R, Tramontano M, Iosa M, Mastrogiacomo S, et al.
Sci Rep
. 2021 Apr;
11(1):7237.
PMID: 33790343
After a stroke event, most survivors suffer from arm paresis, poor motor control and other disabilities that make activities of daily living difficult, severely affecting quality of life and personal...